Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Researchers have a new window into one of brain cancer's deadliest tricks. Scientists at Uppsala University developed GlioTrace, an AI-assisted method that tracks thousands of individual glioblastoma cells moving through living brain tissue. The tool revealed that tumor cells are surprisingly flexible — switching movement styles within days — and that some treatments may push cells toward faster, more invasive forms.
Glioblastoma is notoriously hard to treat, partly because tumor cells slip into surrounding healthy brain tissue beyond what surgeons can remove. Now, researchers at Uppsala University have developed GlioTrace, a method combining automated microscopy with AI to track thousands of individual tumor cells as they move through living brain slices — offering an unprecedented real-time view of cancer invasion.
The team studied glioblastoma cells from six patients, growing them in mouse brains, slicing the tissue, and photographing it every two hours for up to five days. A machine-learning system identified and followed each cell, revealing that tumor cells don't move in one fixed way — they can switch between creeping along blood vessels and pushing independently through tissue, sometimes within just a few days. Separately, a complementary study published in Nature by EMBL and DKFZ researchers confirmed that these state transitions follow predictable, rule-based patterns governed by gene regulatory networks, opening the door to potential reprogramming therapies.
Key Takeaways:
Why it matters: These tools give researchers their clearest look yet at how glioblastoma spreads and adapts. Both GlioTrace and the regulatory atlas are freely available to the research community, accelerating the path toward therapies that don't just shrink tumors, but stop them from spreading.
